News

In Neurology Today: Investigators from multiple academic medical centers are collaborating on an initiative to expand development of potential PET tracers for alpha-synuclein in Parkinson's disease and multiple system atrophy
Featured in PennToday: A Penn-led collaboration of radiology, computational chemistry, and neurology experts will identify and test new tracers for PET scans to help diagnose and monitor diseases.
Our recent paper, "Computational Chemistry for the Identification of Lead Compounds for Radiotracer Development", has been tagged as one of the most popular papers in Pharmaceuticals. Twitter, Facebook
The CW₂IP₂ was featured in the AAN TV Thought Leadership Film Series as part of the American Academy of Neurology 2023 Annual Meeting.
Featured in PennToday: New research describes an innovative method for identifying molecules that can help track the progression of Parkinson’s disease. Conducted by scientists in the labs of E. James Petersson of the School of Arts & Sciences and Robert Mach and Virginia Lee of the Perelman School of Medicine, this proof-of-concept study could change the paradigm for how researchers screen and test new molecules for studying a wide range of neurodegenerative diseases.